ICM
CLVT icon

Invenomic Capital Management’s Clarivate CLVT Stock Holding History

Invenomic Capital Management’s Portfolio CLVT Stock Details CLVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.8M Buy
14,261,471
+951,237
+7% +$2.33M 1.84% 14
2026
Q1 		$33.7M Buy
13,310,234
+4,280,820
+47% +$11M 1.55% 17
2025
Q4 		$30.2M Buy
9,029,414
+326,369
+4% +$1.16M 1.4% 19
2025
Q3 		$33.3M Sell
8,703,045
-682,042
-7% -$2.86M 1.61% 17
2025
Q2 		$40.4M Buy
9,385,087
+904,791
+11% +$3.64M 2.29% 6
2025
Q1 		$33.3M Buy
8,480,296
+1,894,589
+29% +$8.97M 1.68% 14
2024
Q4 		$33.5M Buy
6,585,707
+667,146
+11% +$3.84M 1.59% 10
2024
Q3 		$42M Sell
5,918,561
-835,912
-12% -$5.33M 2.31% 7
2024
Q2 		$38.4M Buy
6,754,473
+342,557
+5% +$2.18M 1.87% 10
2024
Q1 		$47.6M Buy
6,411,916
+1,453,428
+29% +$12.1M 2.53% 2
2023
Q4 		$45.9M Sell
4,958,488
-2,527,756
-34% -$18.7M 2.09% 7
2023
Q3 		$50.2M Buy
7,486,244
+763,368
+11% +$6.09M 2.11% 9
2023
Q2 		$64.1M Buy
6,722,876
+1,253,238
+23% +$10.6M 3.25% 2
2023
Q1 		$51.4M Buy
5,469,638
+2,664,472
+95% +$27.5M 2.9% 2
2022
Q4 		$23.4M Buy
+2,805,166
New +$26.3M 1.59% 18

Other funds holding CLVT

LGP
Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.18B AUM 0.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Edmond de Rothschild Holding
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Invenomic Capital Management's CLVT Position: Q2 2026 in Review

Invenomic Capital Management increased its Clarivate (CLVT) stake by 7.1% in Q2 2026, buying an estimated $2.33M and bringing the position to 14,261,471 shares worth $30.8M. The position accounts for 1.84% of the portfolio, ranked #14.

Invenomic Capital Management first reported a position in CLVT in Q4 2022 and has held it in 15 quarters since. The position peaked at $64.1M in Q2 2023. 242 funds tracked by Wall St. Rank hold CLVT as of Q2 2026.

  • Invenomic Capital Management held 14,261,471 shares of Clarivate worth $30.8M as of Q2 2026.
  • Invenomic Capital Management bought 951,237 Clarivate shares in Q2 2026, an estimated $2.33M.
  • Clarivate made up 1.84% of Invenomic Capital Management's portfolio in Q2 2026, its #14 holding.
  • Invenomic Capital Management first reported a position in Clarivate in Q4 2022 and has held it in 15 quarters since.
  • Invenomic Capital Management's Clarivate position peaked at $64.1M in Q2 2023.
  • 242 funds tracked by Wall St. Rank held Clarivate as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.